Drug Compounders To Congress: Stem FDA's Office-Use Rx Requirements

A group of of pharmacy and healthcare provider organizations is pushing congressional health care committees to take legislative steps to stop FDA from requiring patient-specific prescriptions for office-use compounding, complaining the agency's approach is barring patient access to urgently-needed antibiotics and goes against congressional intent. The letter comes after key brand and generic drug associations conversely threw their weight behind FDA's enforcement approach last month. The International Academy of Compounding Pharmacists, PCCA (Professional Compounding Centers of America), American Medical Association,...